In this work, authors show that retro-inversion of host-defense peptides markedly improves their antitubercular potency and selectivity, highlighting the potential of this simple chemical modification to advance the design of novel antimycobacterial biotherapeutics.
- Hugh D. Glossop
- Gebremichal Gebretsadik
- Scott H. Medina